上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index 2025-10-22 08:30
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year 2025-10-10 08:30
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™，to Accelerate Biologics Development with High Titer and Superior Stability 2025-09-25 19:42
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year 2025-09-23 12:00
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK) 2025-09-17 12:00
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry 2025-09-09 18:00
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi 2025-08-28 17:00
WuXi Biologics Reports Solid 2025 Interim Results 2025-08-19 20:35
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale 2025-08-12 17:00
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules 2025-08-11 16:30
WuXi Biologics Named to A List for CDP Supplier Engagement Assessment 2025-08-07 08:30
WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication 2025-07-29 16:00
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics 2025-07-16 18:00
WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL 2025-06-30 19:00
Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report 2025-04-29 18:47
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year 2025-04-22 16:30
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site 2025-04-18 14:30
WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards 2025-04-14 21:07
WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 2025-03-25 18:30
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year 2025-03-21 08:30
1 2 3 4 5 10